Israel Englander’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,040,504
Closed -$20.4M 7681
2022
Q3
$20.4M Buy
2,040,504
+23,962
+1% +$238K 0.01% 1325
2022
Q2
$19.9M Buy
2,016,542
+1,182,751
+142% +$11.7M 0.01% 1312
2022
Q1
$8.21M Sell
833,791
-18,210
-2% -$179K ﹤0.01% 2381
2021
Q4
$8.32M Sell
852,001
-13,856
-2% -$136K ﹤0.01% 2339
2021
Q3
$8.47M Sell
865,857
-628,529
-42% -$6.15M 0.01% 2281
2021
Q2
$15M Buy
1,494,386
+215,430
+17% +$2.2M 0.01% 1480
2021
Q1
$13.1M Buy
+1,278,956
New +$15.1M 0.01% 1508

Other funds holding HAAC

Israel Englander's HAAC Position: Q4 2022 in Review

Israel Englander sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 2,040,504 shares — an estimated $20.4M sold.

Israel Englander first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $20.4M in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

  • Israel Englander reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Israel Englander sold 2,040,504 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $20.4M.
  • Israel Englander first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Israel Englander's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $20.4M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.